Though miR-421 has been identified to target multiple mRNAs to alter tumor progression, such as FOXO4 [15], MEF2D [26], and MTA1 [27], whether miR-421 can target PDE7B remains to be uncovered. Here, MEF2D is linked to neoplasm.